Akintunde Emiola, Ph.D.

Postdoctoral Associate

Akintunde plans to develop single cell sequencing technology to define "dark matter" microorganisms, and search for bacteria that encode genes for antibiotic resistance or other immune-related function.

Visit The Oh Lab

About Akintunde Emiola, Ph.D.

Akintunde Emiola earned his Master’s and Ph.D. at the University of East London in the United Kingdom. During his doctoral work in systems biology, Akintunde developed and tested algorithms that modeled the step-wise synthesis of Lipid A, a crucial part of the outer membrane in E. coli bacteria. In the Oh lab, Akintunde is interested primarily in the therapeutic potential of the “dark matter,” the unidentified and uncharacterized bacteria living on the human skin. He plans to develop single cell sequencing technology to define these microorganisms, and search for bacteria that encode genes for antibiotic resistance or other immune-related function.

Press ReleaseSeptember 14, 2018
JAX, Azitra receive Department of Defense grant: Bioengineered commensals to fight Staphylococcus aureus
Next-generation anti-infectives designed to address the evolving issue of drug resistance.
Research HighlightSeptember 11, 2018
Exploring zinc finger proteins
The National Institute of General Medical Sciences has awarded Petko Petkov a four-year grant totaling $1,385,337 to exploit the new methods he has developed to profile and investigate zinc finger proteins and their binding sites.
Press ReleaseSeptember 04, 2018
Using mathematical modeling to target infections
When an otherwise harmless fungus like Aspergillus fumigatus invades the lungs of people with compromised immune systems, it can cause severe respiratory problems. A new NIH grant will employ specialized mathematical and computer modeling to improve understanding of our biological defense system.
Press ReleaseAugust 01, 2018
$2M NIH Grant to Study Genetic Mechanisms of Inherited Heart Muscle Disorders
Travis Hinson, M.D., has received more than $2 million from the National Institutes of Health National Heart, Lung, and Blood Institute to study the mechanisms responsible for a serious and often fatal heart condition.
- Cardiovascular
- Genetics and Genomics

Research HighlightSeptember 13, 2018
Distinguishing the helpful from the harmful in the human microbiome
New JAX research offers insight into how our immune cells are able to tell the difference between helpful bacterial strains and potentially inflammatory or pathogenic strains.
Search MagazineSeptember 11, 2018
Non-coding DNA is not junk after all
Assistant Professor Christine Beck, Ph.D., is uncovering how recurring sequences in our genomes might shed light on genome stability, as well as diseases like cancer.
Search MagazineAugust 14, 2018
Understanding our inheritance
To find out more about the complexities of inheritance, JAX spoke with author and New York Times columnist Carl Zimmer, who frequently writes about genetics and evolution.
Research HighlightJuly 12, 2018
The distinct forms of an important genomic disruption
A new paper further explains the genomic disruption known as the tandem duplicator phenotype (TDP), a common attribute in some of the most deadly cancers of women.